Palliative radiation therapy is underutilized across a variety of clinical settings, with reported disparities in palliative radiation therapy administration based on age, race, ethnicity, socioeconomic status and geography.
This activity is dedicated to unraveling the emerging field of focal therapies in oncology, with a specific focus on histotripsy, high-intensity focused ultrasound (HIFU) and electroporation.
This session highlights five of the most clinically relevant abstracts within the Central Nervous System track of the 2024 ASTRO Annual Meeting scientific program.
Although immunotherapy has revolutionized the treatment of cancer, the translation of immunotherapy-radiotherapy (IT-RT) combinations into the clinic has proven challenging.
In the United States, the conventional approach to treating locally advanced rectal cancer has traditionally combined preoperative chemoradiotherapy, total mesorectal excision and adjuvant chemotherapy.
Pancreato-biliary cancers, mainly pancreatic cancer and extrahepatic cholangiocarcinoma, are almost uniformly fatal malignancies with increasing incidence and poor prognosis even when diagnosed in the early stages of the disease.
Patient fertility and sexual complications have few data available from clinical trials. It is noteworthy that the subject is infrequently discussed in institutional peer reviews/ M&M unless there is a Risk Management overlay.
Radiation therapy-induced erectile dysfunction (RI-ED) occurs in over 50% of men treated for prostate cancer. The etiologies are likely multifactorial, consisting of a neurological, vascular and endocrine component.
This session highlights the most clinically relevant abstracts within the Head and Neck Cancer track of the 2024 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.
Facebook
X
LinkedIn
Forward
